A randomised clinical trial to assess the adjuvant potential of methotrexate to corticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris

Abstract Glucocorticoids are the mainstay of treatment for pemphigus vulgaris (PV). However, the requirement of high doses for long durations often leads to serious adverse events. Methotrexate as an adjuvant has shown potential in retrospective studies but randomized trials are lacking. The objecti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khimit Jain, Vishal Thakur, Sanjeev Handa, Neha Thakur, Shilpa, Naresh Sachdeva, Rahul Mahajan, Dipankar De
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Portfolio 2022-05-01
Edice:Scientific Reports
On-line přístup:https://doi.org/10.1038/s41598-022-11387-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky